Estrogens, Conjugated
Brand name: Premarin
Rank #246 of 500 drugs by total cost
$52.0M
Total Cost
130,171
Total Claims
$52.0M
Total Cost
6,652
Prescribers
$399
Cost per Claim
18,379
Beneficiaries
249,512
30-Day Fills
$7,815
Avg Cost/Provider
20
Avg Claims/Provider
About Estrogens, Conjugated
Estrogens, Conjugated (sold as Premarin) was prescribed 130,171 times by 6,652 Medicare Part D providers in 2023, costing the program $52.0M. At $399 per claim, this is a moderately priced medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 243 | Raltegravir Potassium (Isentress) | $53.0M | 25,491 |
| 244 | Belumosudil Mesylate (Rezurock) | $52.3M | 2,280 |
| 245 | Pegloticase (Krystexxa) | $52.2M | 1,134 |
| 246 | Estrogens, Conjugated (Premarin) | $52.0M | 130,171 |
| 247 | Ranolazine (Ranolazine Er) | $51.6M | 381,631 |
| 248 | Epoetin Alfa (Epogen) | $51.4M | 34,952 |
| 249 | Nifedipine (Nifedipine Er) | $51.2M | 1,249,866 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology